The EU’s Chance to Tackle Superbugs and Shortages
As the European Commission gets set to review the EU’s pharmaceutical legislation, two issues demand particular attention: ensuring supplies of key medicines, especially antibiotics—and encouraging the innovation needed to maintain the therapeutic options available, which come from having new and different antibiotics.
By Francesca Scassellati Sforzolini
23 March 2023